Diagnostics

Nearly 90% of U.S. gastroenterologists are open to using AI for help performing high quality colonoscopies. And of these, 85% believe that computer-assisted polyp detection (CADe) stands to improve their endoscopic performance.

A supplier of healthcare software in the respiratory care space has received the FDA’s blessing to market deep learning elements newly added to an existing product.

The novel AI-aided app can run on both Apple and Android operating systems and only needs to be placed near the would-be sleeper—a familiar nightstand, shelf or end table will do—at bedtime.

Researchers at West Virginia University are well placed to tap AI for teasing out the role of existing respiratory concerns in the progression of COVID-19.

Machine learning can help post-childbirth mothers guard against problems with subsequent pregnancies, potentially saving their lives and those of their future babies.

Along with new or improved algorithmic applications for chest imaging, watch for word of an AI-powered breathalyzer and other diagnostic techno-weapons aimed at COVID. What they’ll all have in common is full-throated NIH support.

Researchers at New York University have demonstrated an AI-based way to send COVID patients from the ER to the most appropriate care setting according to their individualized risk.  

Industry researchers in medical AI have demonstrated a “causal reasoning” algorithm whose diagnostic accuracy would place it among the top 25% of primary care doctors in the U.K. 

Someone had to come right out and ask. Six researchers representing four medical specialties have done so, weighing the odds by reviewing a representative sample of the literature.

Researchers have demonstrated the use of an AI tool that can accurately identify or rule out prostate cancer on digitized pathology slides from core needle biopsies.

The FDA has OK’d the sixth medical AI application developed by Israel-based Zebra Medical Vision. The latest iteration helps breast-specialized radiologists by flagging questionable lesions appearing in 2D mammograms.

The COVID crisis could close the gap between what healthcare AI can do in clinical research settings and how it can contribute to actual patient care.

Around the web

Two different companies announced that they are recalling all lots of the medication. 

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

   
   
   
   
   
Trimed Popup
Trimed Popup